Regeneron Pharmaceuticals, Inc. (NASDAQ: REGN) will partake in a panel discussion at the 2010 Healthcare Conference held by RBC Capital Markets. The panel, which has been titled “Building a Proprietary and Partnered Pipeline of Antibodies”, is scheduled to take place at 2:05pm (EST) on March 3, 2010. The discussion can be accessed via webcast through the company’s website.
Top Best Penny Stocks, a leading financial publication, is pleased to alert investors of stocks on the move. Sign up for our Free Stock Newsletter.
Regeneron is a fully integrated biopharmaceutical company that discovers, develops, and commercializes medicines for the treatment of serious medical conditions.
Sign up for Top Best Penny Stocks' free newsletter. To subscribe, enter your e-mail address into the frame at the bottom of this press release or visit our website.
Follow us on Twitter: http://www.Twitter.com/topbestps
About Us
Top Best Penny Stocks is a leading stock web site that allows investors and interested parties to research stocks that are on the move. We also track small cap companies that are on the brink of a financial breakout. To feature a company on our web site please contact us at the email listed below.
Please click here to read the full disclaimer.
